We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)


Efficacy endpoint met in Phase II AML study

Lighthouse | 02 April 2019


Further support for bemcentinib’s broad potential from preclinical data at AACR

Lighthouse | 01 April 2019


Terms of the rights issue announced

Lighthouse | 28 March 2019

Hutchison China MediTech

Bringing Global Innovation and China Oncology into focus

Update | 21 March 2019


Securing the commercial future of NBT in depression

Update | 18 March 2019

Hutchison China MediTech

FY18 results as expected, plentiful news flow in FY19

Lighthouse | 11 March 2019


Setting the stage

Update | 06 March 2019


Resolution of Rigel arbitration reduces uncertainty

Lighthouse | 01 March 2019


Gearing up for growth

Update | 01 March 2019

Hutchison China MediTech

ASCO GU: promising PRCC data for savo/durva combo

Update | 20 February 2019
1 2 3 4 5 6 7 8 9 10 11
105 results found.